cDNA - Liver Cirrhosis: Liverfrom Biochain |
|
| C1236149Lcs | 40 reactions: 589.40 EUR |
|
Liver Liver Cirrhosis Lysatefrom ProSci |
|
| XBL-10358 | 0.1 mg: 796.20 EUR |
|
|
Description: Human liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The human liver tissue total protein is provided in a buffer including HEPES (pH7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|
Liver Membrane Liver Cirrhosis Lysatefrom ProSci |
|
| XBL-10671 | 0.1 mg: 752.10 EUR |
|
|
Description: Human liver tissue membrane protein lysate was prepared by isolating the membrane protein from whole tissue homogenates using a proprietary technique. The human liver tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The membrane protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the isolated liver tissue membrane protein pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The isolated liver tissue membrane protein is then Western analyzed by either GAPDH or β-actin antibody to confirm there is no signal or very weak signal. |
|
Liver cancer and liver tissue arrayfrom TissueArray |
|
| BC03116a | each: 306.00 EUR |
|
|
Description: Liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 70 cases/70 cores, replacing BC03116 |
|
Liver tumor with liver tissue arrayfrom TissueArray |
|
| T032d | each: 48.00 EUR |
|
|
Description: Liver tumor with liver tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores, replacing T032c |
|
Liver cancer with liver tissue arrayfrom TissueArray |
|
| LV1021a | each: 204.00 EUR |
|
|
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 102 cases/102 cores, replacing LV1021 |
|
Liver cancer with liver tissue arrayfrom TissueArray |
|
| LV243 | each: 66.00 EUR |
|
|
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 12 cases/24 cores |
|
Liver cancer with liver tissue arrayfrom TissueArray |
|
| LV722 | each: 306.00 EUR |
|
|
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 24 cases/72 cores, replacing LV721 |
|
Liver cancer with liver tissue arrayfrom TissueArray |
|
| LV803b | each: 270.00 EUR |
|
|
Description: Liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 54 cases/72 cores, replacing LV803a |
|
Human Liver Cirrhosis Liver Tissue Lysatefrom Innovative research |
|
| IHULRCIRTL100UG | each: 1413.00 EUR |
|
|
Description: Human Liver Cirrhosis Liver Tissue Lysate |
|
Human Liver Cirrhosis Liver Tissue Lysatefrom MyBiosource |
|
| MBS8414653-01mg | 0.1mg: 1810.00 EUR |
|
Human Liver Cirrhosis Liver Tissue Lysatefrom MyBiosource |
|
| MBS8414653-5x01mg | 5x0.1mg: 7965.00 EUR |
|
OCPB00553-100UG - Liver Liver Cirrhosis Lysatefrom Aviva Systems Biology |
|
| OCPB00553-100UG | 0.1mg: 739.00 EUR |
|
Liver cancer and normal liver tissue arrayfrom TissueArray |
|
| LV483a | each: 198.00 EUR |
|
|
Description: Liver cancer and normal liver tissue array, including hepatocellular carcinoma,cholangiocellular carcinoma and normal tissues pathology grade, TNM and clinical stage (AJCC 7th edition), 48 cases/48 cores (core size 1.5mm), replacing LV483 |
|
Liver cancer with matched liver tissue arrayfrom TissueArray |
|
| LV241b | each: 66.00 EUR |
|
|
Description: Liver cancer with matched liver tissue array, including pathology grade, TNM and clinical stage, 6 cases/24 cores, replacing LV241a |
|
Human Liver Cirrhosis Liver Lysate Membrane Fractionfrom Innovative research |
|
| IHULRCIRTLM100UG | each: 1199.00 EUR |
|
|
Description: Human Liver Cirrhosis Liver Lysate Membrane Fraction |
|
Human Liver Cirrhosis Liver Lysate Membrane Fractionfrom MyBiosource |
|
| MBS8414654-01mg | 0.1mg: 1550.00 EUR |
|
Human Liver Cirrhosis Liver Lysate Membrane Fractionfrom MyBiosource |
|
| MBS8414654-5x01mg | 5x0.1mg: 6780.00 EUR |
|
Chang Liverfrom AcceGen |
|
| ABL-TC0127 | 1 vial: Ask for price |
|
|
Description: Chang Liver Cell Line is from human; Tissue: HeLa-contaminant; Morphology: epithelial-like; Profile: Hela markers*. |
|
Human Liverfrom ABM |
|
| HS0032 | 6 Slides/Pack: 160.00 EUR |
|
OCPB00662-100UG - Liver Membrane Liver Cirrhosis Lysatefrom Aviva Systems Biology |
|
| OCPB00662-100UG | 0.1mg: 689.00 EUR |
|
Liver Lysatefrom ProSci |
|
| 21-105 | 0.1 mg: 342.60 EUR |
|
|
Description: Bovine liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The bovine liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|
Liver Lysatefrom ProSci |
|
| 21-406 | 0.1 mg: 342.60 EUR |
|
|
Description: Porcine liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The porcine liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|
Liver Lysatefrom ProSci |
|
| 21-419 | 0.1 mg: 342.60 EUR |
|
|
Description: Rabbit liver tissue lysate was prepared by homogenization using a proprietary technique. The tissue was frozen in liquid nitrogen immediately after excision and then stored at -70°C. The rabbit liver tissue total protein is provided in a buffer including HEPES (pH 7.9), MgCl2, KCl, EDTA, Sucrose, Glycerol, Sodium deoxycholate, NP-40, and a cocktail of protease inhibitors. For quality control purposes, the liver tissue pattern on SDS-PAGE gel is shown to be consistent for each lot by visualization with coomassie blue staining. The liver tissue is then Western analyzed by either GAPDH or β-actin antibody, and the expression level is consistent with each lot. |
|
Liver Lysatefrom ProSci |
|
| 1464 | 0.1 mg: 229.20 EUR |
|
|
Description: Liver tissue lysate was prepared by homogenization in modified RIPA buffer (150 mM sodium chloride, 50 mM Tris-HCl, pH 7.4, 1 mM ethylenediaminetetraacetic acid, 1 mM phenylmethylsulfonyl fluoride, 1% Triton X-100, 1% sodium deoxycholic acid, 0.1% sodium dodecylsulfate, 5 μg/ml of aprotinin, 5 μg/ml of leupeptin. Tissue and cell debris was removed by centrifugation. Protein concentration was determined with Bio-Rad protein assay. The product was boiled for 5 min in 1 x SDS sample buffer (50 mM Tris-HCl pH 6.8, 12.5% glycerol, 1% sodium dodecylsulfate, 0.01% bromophenol blue) containing 50 mM DTT. |
|
Liver cancerfrom TissueArray |
|
| BC03117 | each: 306.00 EUR |
|
|
Description: Liver cancer, liver cirrhosis tissue array with normal tissue as control, including TNM, clinical stage, pathology grade and history of hepatitis, 70 cases/ 80 cores, replaced by BC03117a |
|
Liver tissuefrom TissueArray |
|
| LV805b | each: 270.00 EUR |
|
|
Description: Liver tissue, hepatitis and cirrhosis tissue array, 80 cases/80 cores, replacing LV805a |
|
Liver Lysatefrom MyBiosource |
|
| MBS151614-01mg | 0.1mg: 200.00 EUR |
|
Liver Lysatefrom MyBiosource |
|
| MBS151614-5x01mg | 5x0.1mg: 880.00 EUR |
|
Liver Lysatefrom MyBiosource |
|
| MBS151657-01mg | 0.1mg: 200.00 EUR |
|
Liver Lysatefrom MyBiosource |
|
| MBS151657-5x01mg | 5x0.1mg: 880.00 EUR |
|
Liver Lysatefrom MyBiosource |
|
| MBS151762-01mg | 0.1mg: 200.00 EUR |
|
Liver Lysatefrom MyBiosource |
|
| MBS151762-5x01mg | 5x0.1mg: 880.00 EUR |
|
Liver, Rabbitfrom MyBiosource |
|
| MBS639359-20Each | 20Each: 355.00 EUR |
|
Liver, Rabbitfrom MyBiosource |
|
| MBS639359-5x20Each | 5x20Each: 1385.00 EUR |
|
Hepatitis B liver cancer and liver tissue arrayfrom TissueArray |
|
| LV1401 | each: 474.00 EUR |
|
|
Description: Hepatitis B liver cancer and liver tissue array, including pathology grade, TNM, clinical stage and HBV data, 99 cases/140 cores |
|
High density liver cancer with liver tissue arrayfrom TissueArray |
|
| LV208 | each: 546.00 EUR |
|
|
Description: High density liver cancer with liver tissue array, including pathology grade, TNM and clinical stage., 69 cases/207 cores |
|
High density liver cancer with liver tissue arrayfrom TissueArray |
|
| LV2091 | each: 474.00 EUR |
|
|
Description: High density liver cancer with liver tissue array, including pathology grade, TNM and clinical stage, 208 cases/208 cores |
|
Liver cancer and normal adjacent liver tissue arrayfrom TissueArray |
|
| LV801b | each: 306.00 EUR |
|
|
Description: Liver cancer and normal adjacent liver tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores (1.5mm), replacing LV801a |
|
Liver Arginasefrom EnoGene |
|
| E8ET7107-90 | 100ul: 275.00 EUR |
|
|
Description: Available in various conjugation types. |
|
Liver Arginasefrom MyBiosource |
|
| MBS8565816-01mL | 0.1mL: 345.00 EUR |
|
Liver Arginasefrom MyBiosource |
|
| MBS8565816-01mLAF405L | 0.1mL(AF405L): 565.00 EUR |
|
Liver Arginasefrom MyBiosource |
|
| MBS8565816-01mLAF405S | 0.1mL(AF405S): 565.00 EUR |
|
Liver Arginasefrom MyBiosource |
|
| MBS8565816-01mLAF610 | 0.1mL(AF610): 565.00 EUR |
|
Liver Arginasefrom MyBiosource |
|
| MBS8565816-01mLAF635 | 0.1mL(AF635): 565.00 EUR |
|
Liver cancer with adjacent normal liver tissue arrayfrom TissueArray |
|
| LV242a | each: 66.00 EUR |
|
|
Description: Liver cancer with adjacent normal liver tissue array, including pathology grade, TNM and clinical stage (reference AJCC 7th version), 12 cases/24 cores, replacing LV242 |
|
Tissue, Total Protein, Human Disease, Liver Cirrhosis, Liverfrom MyBiosource |
|
| MBS657558-1mg | 1mg: 820.00 EUR |
|
Tissue, Total Protein, Human Disease, Liver Cirrhosis, Liverfrom MyBiosource |
|
| MBS657558-5x1mg | 5x1mg: 3470.00 EUR |
|
Liver Concentratefrom Pfaltz & Bauer |
|
| L04640 | 500G: 154.40 EUR |
|
|
Description: CAS N° 8002-47-9 |
|
Total-RNA---Liver-Cirrhosis:-Liverfrom Biochain |
|
| R1236149Lcs-50 | 50 ug: 338.10 EUR |
|
Tissue, Section, Human Disease, Liver Cirrhosis, Liver (Paraffin)from MyBiosource |
|
| MBS640771-5Sections | 5Sections: 510.00 EUR |
|
Tissue, Section, Human Disease, Liver Cirrhosis, Liver (Paraffin)from MyBiosource |
|
| MBS640771-5x5Sections | 5x5Sections: 2145.00 EUR |
|
Tissue, Membrane Protein, Human Disease, Liver Cirrhosis, Liverfrom MyBiosource |
|
| MBS639877-01mg | 0.1mg: 695.00 EUR |
|
Tissue, Membrane Protein, Human Disease, Liver Cirrhosis, Liverfrom MyBiosource |
|
| MBS639877-5x01mg | 5x0.1mg: 2915.00 EUR |
|
Genomic DNA - Liver Cirrhosis: Liver, from a single donorfrom Biochain |
|
| D1236149Lcs | 50 ug: 413.00 EUR |
|
Different stages of liver cancer and liver tissue arrayfrom TissueArray |
|
| LV808 | each: 306.00 EUR |
|
|
Description: Different stages of liver cancer and liver tissue array, including pathology grade, TNM and clinical stage, 80 cases/80 cores |
|
Total-Protein---Liver-Cirrhosis:-Liverfrom Biochain |
|
| P1236149Lcs | 1 mg: 398.30 EUR |
|
Dog Liver RNAfrom Zyagen |
|
| DR-314 | 0.1mg: 195.00 EUR |
|
Liver cancer with matched cancer adjacent liver tissue arrayfrom TissueArray |
|
| LV1505a | each: 258.00 EUR |
|
|
Description: Liver cancer with matched cancer adjacent liver tissue array, including pathology grade, TNM and clinical stage, replacing LV1505 |
|
Membrane-Protein---Liver-Cirrhosis:-Liverfrom Biochain |
|
| P3236149Lcs | 0.1 mg: 346.85 EUR |
|
Dog Liver cDNAfrom Zyagen |
|
| DD-314 | 30 Reactions: 280.00 EUR |
|
Cat Liver cDNAfrom Zyagen |
|
| FD-314 | 30 Reactions: 280.00 EUR |
|
Pig Liver cDNAfrom Zyagen |
|
| PD-314 | 30 reactions: 243.00 EUR |
|
Rat Liver cDNAfrom Zyagen |
|
| RD-314 | 30 reactions: 243.00 EUR |
|
Rat Liver Cellsfrom AcceGen |
|
| ABC-TC4151 | 1 vial: Ask for price |
|
|
Description: Rat primary liver cells (RPLIC) are isolated from tissue of 1-day-old neonatal Sprague–Dawley rats. Rat primary liver cells are mixed population of mouse liver cells grown in T75 tissue culture flasks pre-coated with 0.2% gelatin for 1 hour and incubate in Culture Complete Growth Medium. |
|
Liver Veal Agarfrom Solarbio Life Science |
|
| LA8730 | 250 g: Ask for price |
|
Tissue, Total RNA, Human Disease, Liver Cirrhosis, Liver, BioGenomicsfrom MyBiosource |
|
| MBS638514-005mg | 0.05mg: 655.00 EUR |
|
Tissue, Total RNA, Human Disease, Liver Cirrhosis, Liver, BioGenomicsfrom MyBiosource |
|
| MBS638514-5x005mg | 5x0.05mg: 2735.00 EUR |
|
Human Liver CAFsfrom Neuromics |
|
| CAF113 | 1,000,000 cells: 3078.00 EUR |
|
Chang Liver (HeLa)from Addexbio |
|
| C0050007 | One Frozen vial: 420.00 EUR |
|
cDNA - Lupus: Liverfrom Biochain |
|
| C1236149Lup | 40 reactions: 596.05 EUR |
|
Sheep Liver cDNAfrom Zyagen |
|
| SD-314 | 30 reactions: 243.00 EUR |
|
Liver Broth Agarfrom Solarbio Life Science |
|
| LA7930 | 250 g: Ask for price |
|
Tissue, Genomic DNA, Human Disease, Liver Cirrhosis, Liver, BioGenomicsfrom MyBiosource |
|
| MBS654495-005mg | 0.05mg: 715.00 EUR |
|
Tissue, Genomic DNA, Human Disease, Liver Cirrhosis, Liver, BioGenomicsfrom MyBiosource |
|
| MBS654495-5x005mg | 5x0.05mg: 3075.00 EUR |
|
Bovine Liver cDNAfrom Zyagen |
|
| BD-314 | 30 reactions: 243.00 EUR |
|
Equine Liver cDNAfrom Zyagen |
|
| ED-314 | 30 reactions: 319.00 EUR |
|
Ferritin, Liver (AP)from MyBiosource |
|
| MBS6475876-01mL | 0.1mL: 800.00 EUR |
|
Ferritin, Liver (AP)from MyBiosource |
|
| MBS6475876-5x01mL | 5x0.1mL: 3445.00 EUR |
|
Ferritin, Liver (AP)from MyBiosource |
|
| MBS6475881-01mL | 0.1mL: 1040.00 EUR |
|
Ferritin, Liver (AP)from MyBiosource |
|
| MBS6475881-5x01mL | 5x0.1mL: 4535.00 EUR |
|
Ferritin, Liver (PE)from MyBiosource |
|
| MBS6475883-01mL | 0.1mL: 800.00 EUR |
|
Ferritin, Liver (PE)from MyBiosource |
|
| MBS6475883-5x01mL | 5x0.1mL: 3445.00 EUR |
|
Ferritin, Liver (PE)from MyBiosource |
|
| MBS6475892-01mL | 0.1mL: 1040.00 EUR |
|
Ferritin, Liver (PE)from MyBiosource |
|
| MBS6475892-5x01mL | 5x0.1mL: 4535.00 EUR |
|
Rabbit Liver cDNAfrom Zyagen |
|
| TD-314 | 30 reactions: 243.00 EUR |
|
Liver cancer tissue array with normal liver tissue as controlfrom TissueArray |
|
| T033b | each: 66.00 EUR |
|
|
Description: Liver cancer tissue array with normal liver tissue as control, including pathology grade, TNM and clinical stage, 2 serial sections, 6 cases/ 24 cores, replacing T033a |
|
BOVINE, LIVER, FRESHfrom Lampire Biologicals Laboratories |
|
| 8600835 | 1EA: 86.13 EUR |
|
